Dao Wang to Biomarkers
This is a "connection" page, showing publications Dao Wang has written about Biomarkers.
Connection Strength
0.234
-
The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage. Biosci Rep. 2021 03 26; 41(3).
Score: 0.042
-
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol. 2020 10; 147:74-87.
Score: 0.041
-
Cardiac injuries in coronavirus disease 2019 (COVID-19). J Mol Cell Cardiol. 2020 08; 145:25-29.
Score: 0.040
-
Serum MicroRNA-27b as a Screening Biomarker for Left Ventricular Hypertrophy. Tex Heart Inst J. 2017 12; 44(6):385-389.
Score: 0.034
-
Increased Cathepsin D Correlates with Clinical Parameters in Newly Diagnosed Type 2 Diabetes. Dis Markers. 2017; 2017:5286408.
Score: 0.034
-
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol. 2020 09; 17(9):992-994.
Score: 0.010
-
Serum vitamin D deficiency and vitamin D receptor gene polymorphism are associated with increased risk of cardiovascular disease in a Chinese rural population. Nutr Res. 2019 01; 61:13-21.
Score: 0.009
-
Plasma metabolic profile reveals PGF2a protecting against non-proliferative diabetic retinopathy in patients with type 2 diabetes. Biochem Biophys Res Commun. 2018 02 19; 496(4):1276-1283.
Score: 0.009
-
Direct reprogramming of mouse fibroblasts into neural cells via Porphyra yezoensis polysaccharide based high efficient gene co-delivery. J Nanobiotechnology. 2017 Nov 14; 15(1):82.
Score: 0.008
-
Predictive factors and clinical practice profile for strictures post-necrotising enterocolitis. Medicine (Baltimore). 2017 Mar; 96(10):e6273.
Score: 0.008